Streptococcus suis capsular polysaccharide inhibits phagocytosis through destabilization of lipid microdomains and prevents lactosylceramide-dependent recognition

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 506-517

  Houde, Mathieu ^a   Gottschalk, Marcelo ^a   Gagnon, Fleur ^b   Van Calsteren, Marie Rose ^b   Segura, Mariela ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b FOOD RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; FILIPIN; FLUORESCENT DYE; LACTOSYLCERAMIDE; LATEX; LIPID; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; ENCAPSULATION; IMMUNOFLUORESCENCE; INFECTION; MACROPHAGE; MUTANT; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS SUIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; BACTERIAL ADHESION; CARBOHYDRATE CONFORMATION; CELLS, CULTURED; FEMALE; FILIPIN; GENE EXPRESSION REGULATION, BACTERIAL; LACTOSYLCERAMIDES; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; MICROSPHERES; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS SUIS; VIRULENCE;

EID: 84857164149     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05734-11     Document Type: Article

References (52)

1. Abraham SN, Duncan MJ, Li G, Zaas D. 2005. Bacterial penetration of the mucosal barrier by targeting lipid rafts. J. Investig. Med. 53:318 -321.
2. Baums CG, Valentin-Weigand P. 2009. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim. Health Res. Rev. 10:65-83.
3. Benga L, Fulde M, Neis C, Goethe R, Valentin-Weigand P. 2008. Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes. Vet. Microbiol. 132:211-219.
4. Carlin AF, et al. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333-3336.
5. Chabot-Roy G, Willson P, Segura M, Lacouture S, Gottschalk M. 2006. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 41:21-32.
6. Charland N, Harel J, Kobisch M, Lacasse S, Gottschalk M. 1998. Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology 144:325-332.
7. Charland N, Jacques M, Lacouture S, Gottschalk M. 1997. Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology 143:3607-3614.
8. Cornacchione P, et al. 1998. Group B streptococci persist inside macrophages. Immunology 93:86 -95.
9. Dale JB, Washburn RG, Marques MB, Wessels MR. 1996. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64:1495-1501.
10. Darveau RP. 2009. Bacteria modulate host-cell responses by capitalizing on the lipid raft structure. Future Microbiol. 4:155-157.
11. Dermine JF, Goyette G, Houde M, Turco SJ, Desjardins M. 2005. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell. Microbiol. 7:1263-1270.
12. Desjardins M, Griffiths G. 2003. Phagocytosis: latex leads the way. Curr. Opin. Cell Biol. 15:498 -503.
13. Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78:857-902.
14. Dominguez-Punaro MC, et al. 2010. In vitro characterization of the microglial inflammatory response to Streptococcus suis, an important emerging zoonotic agent of meningitis. Infect. Immun. 78:5074 -5085.
15. Fox JD, Robyt JF. 1991. Miniaturization of three carbohydrate analyses using a microsample plate reader. Anal. Biochem. 195:93-96.
16. Goluszko P, Popov V, Wen J, Jones A, Yallampalli C. 2008. Group B Streptococcus exploits lipid rafts and phosphoinositide 3-kinase/Akt signaling pathway to invade human endometrial cells. Am. J. Obstet. Gynecol. 199:548.e1-548.e9.
17. Gottschalk M, Segura M. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76:259 -272.
18. Gottschalk M, Segura M, Xu J. 2007. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 8:29-45.
19. Gottschalk M, Xu J, Calzas C, Segura M. 2010. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 5:371-391.
20. Graveline R, Segura M, Radzioch D, Gottschalk M. 2007. TLR2- dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int. Immunol. 19:375-389.
21. Guttormsen HK, et al. 2008. Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc. Natl. Acad. Sci. U. S. A. 105:5903-5908.
22. Higgins R, Gottschalk M. 1990. An update on Streptococcus suis identification. J. Vet. Diagn. Invest. 2:249 -252.
23. Houde M, et al. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-406.
24. Iwabuchi K, Nagaoka I. 2002. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100:1454 -1464.
25. Jansson L, Tobias J, Lebens M, Svennerholm AM, Teneberg S. 2006. The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a glycosphingolipid binding protein. Infect. Immun. 74:3488 -3497.
26. Kasper DL. 1986. Bacterial capsule-old dogmas and new tricks. J. Infect. Dis. 153:407-415.
27. Lecours MP, et al. 2011. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J. Infect. Dis. 204:919 -929.
28. Lecours MP, et al. 2011. Characterization of porcine dendritic cell response to Streptococcus suis. Vet. Res. 42:72-84.
29. Manes S, del Real G, Martinez AC. 2003. Pathogens: raft hijackers. Nat. Rev. Immunol. 3:557-568.
30. Nagao G, Ishii K, Hirota K, Makino K, Terada H. 2011. Role of lipid rafts in innate immunity and phagocytosis of polystyrene latex microspheres. Colloids Surf. B Biointerfaces 84:317-324.
31. Nakayama H, et al. 2008. Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J. Leukoc. Biol. 83:728 -741.
32. Pannu R, Won JS, Khan M, Singh AK, Singh I. 2004. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferongamma- mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J. Neurosci. 24:5942-5954.
33. Prasad SM, Yin Y, Rodzinski E, Tuomanen EI, Masure HR. 1993. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect. Immun. 61:2780 -2785.
34. Rohde M, Muller E, Chhatwal GS, Talay SR. 2003. Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol. 5:323-342.
35. Segura M, Cleroux P, Gottschalk M. 1998. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol. Med. Microbiol. 21:189 -195.
36. Segura M, Gottschalk M. 2002. Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect. Immun. 70:4312-4322.
37. Segura M, Gottschalk M, Olivier M. 2004. Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect. Immun. 72:5322-5330.
38. Segura M, Stankova J, Gottschalk M. 1999. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 67: 4646-4654.
39. Severi E, Hood DW, Thomas GH. 2007. Sialic acid utilization by bacterial pathogens. Microbiology 153:2817-2822.
40. Sharma A, Qadri A. 2004. Vi polysaccharide of Salmonella Typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 101: 17492-17497.
41. Smith HE, et al. 1999. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67:1750 -1756.
42. Timoney JF. 2004. The pathogenic equine streptococci. Vet. Res. 35:397-409.
43. Valentin-Weigand P, Benkel P, Rohde M, Chhatwal GS. 1996. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 64:2467-2473.
44. Van Calsteren MR, Gagnon F, Lacouture S, Fittipaldi N, Gottschalk M. 2010. Structure determination of Streptococcus suis serotype 2 capsular polysaccharide. Biochem. Cell Biol. 88:513-525.
45. Vieira FS, Correa G, Einicker-Lamas M, Coutinho-Silva R. 2010. Hostcell lipid rafts: a safe door for micro-organisms? Biol. Cell 102:391-407.
46. Wang M, Hajishengallis G. 2008. Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell. Microbiol. 10:2029 -2042.
47. Ward PN, Field TR, Ditcham WG, Maguin E, Leigh JA. 2001. Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis. Infect. Immun. 69:392-399.
48. Williams AE, Blakemore WF. 1990. Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 162:474-481.
49. Xu S, Huo J, Gunawan M, Su IH, Lam KP. 2009. Activated dectin-1 localizes to lipid raft microdomains for signaling and activation of phagocytosis and cytokine production in dendritic cells. J. Biol. Chem. 284: 22005-22011.
50. Ye C, et al. 2006. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg. Infect. Dis. 12:1203-1208.
51. Yoshizaki F, et al. 2008. Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim. Biophys. Acta 1780:383-392.
52. Zaas DW, Duncan M, Rae Wright J, Abraham SN. 2005. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim. Biophys. Acta 1746:305-313.